Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

the Com-COV2 Study Group; Wanwisa Dejnirattisai; Robert H Shaw; Piyada Supasa; Chang Liu; Arabella SV Stuart; Andrew J Pollard; Xinxue Liu; Teresa Lambe; Derrick Crook; David Stuart; Juthathip Mongkolsapaya; Jonathan S Nguyen-Van-Tam; Matthew D Snape; Gavin R Screaton

doi:10.1016/S0140-6736(21)02844-0

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

the Com-COV2 Study Group, Wanwisa Dejnirattisai, Robert H Shaw, Piyada Supasa, Chang Liu, Arabella SV Stuart, Andrew J Pollard, Xinxue Liu, Teresa Lambe, Derrick Crook, David Stuart, Juthathip Mongkolsapaya, Jonathan S Nguyen-Van-Tam, Matthew D Snape^*, Gavin R Screaton

^*Corresponding author for this work

Chemical Engineering

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	234-236
Number of pages	3
Journal	The Lancet
Volume	399
Issue number	10321
Early online date	20 Dec 2021
DOIs	https://doi.org/10.1016/S0140-6736(21)02844-0
Publication status	Published - 15 Jan 2022

Access to Document

10.1016/S0140-6736(21)02844-0

https://nottingham-repository.worktribe.com/index.php/output/7057921/reduced-neutralisation-of-sars-cov-2-omicron-b11529-variant-by-post-immunisation-serum

Cite this

the Com-COV2 Study Group, Dejnirattisai, W., Shaw, R. H., Supasa, P., Liu, C., Stuart, A. SV., Pollard, A. J., Liu, X., Lambe, T., Crook, D., Stuart, D., Mongkolsapaya, J., Nguyen-Van-Tam, J. S., Snape, M. D., & Screaton, G. R. (2022). Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. The Lancet, 399(10321), 234-236. https://doi.org/10.1016/S0140-6736(21)02844-0

@article{40eba7a2dadb429aa70d5f026d744108,

title = "Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum",

author = "{the Com-COV2 Study Group} and Wanwisa Dejnirattisai and Shaw, {Robert H} and Piyada Supasa and Chang Liu and Stuart, {Arabella SV} and Pollard, {Andrew J} and Xinxue Liu and Teresa Lambe and Derrick Crook and David Stuart and Juthathip Mongkolsapaya and Nguyen-Van-Tam, {Jonathan S} and Snape, {Matthew D} and Screaton, {Gavin R} and Christopher Green",

year = "2022",

month = jan,

day = "15",

doi = "10.1016/S0140-6736(21)02844-0",

language = "English",

volume = "399",

pages = "234--236",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "10321",

}

the Com-COV2 Study Group, Dejnirattisai, W, Shaw, RH, Supasa, P, Liu, C, Stuart, ASV, Pollard, AJ, Liu, X, Lambe, T, Crook, D, Stuart, D, Mongkolsapaya, J, Nguyen-Van-Tam, JS, Snape, MD & Screaton, GR 2022, 'Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum', The Lancet, vol. 399, no. 10321, pp. 234-236. https://doi.org/10.1016/S0140-6736(21)02844-0

TY - JOUR

T1 - Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

AU - the Com-COV2 Study Group

AU - Dejnirattisai, Wanwisa

AU - Shaw, Robert H

AU - Supasa, Piyada

AU - Liu, Chang

AU - Stuart, Arabella SV

AU - Pollard, Andrew J

AU - Liu, Xinxue

AU - Lambe, Teresa

AU - Crook, Derrick

AU - Stuart, David

AU - Mongkolsapaya, Juthathip

AU - Nguyen-Van-Tam, Jonathan S

AU - Snape, Matthew D

AU - Screaton, Gavin R

AU - Green, Christopher

PY - 2022/1/15

Y1 - 2022/1/15

U2 - 10.1016/S0140-6736(21)02844-0

DO - 10.1016/S0140-6736(21)02844-0

M3 - Letter

SN - 0140-6736

VL - 399

SP - 234

EP - 236

JO - The Lancet

JF - The Lancet

IS - 10321

ER -